Zobrazeno 1 - 10
of 16
pro vyhledávání: '"Manuela Iero"'
Autor:
Licia Rivoltini, Matteo Bellone, Stefano Fais, Martina Borghi, Mario Santinami, Luca Generoso, Giorgio Parmiani, Veronica Huber, Monica Rossetti, Elena Jachetti, Rossella Canese, Agata Cova, Alessia Ricupito, Angelo De Milito, Manuela Iero, Matteo Grioni, Paola Filipazzi, Arianna Calcinotto
PDF file - 136K
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::be4e03f5b2b2f996d71422bed9215a94
https://doi.org/10.1158/0008-5472.22393077.v1
https://doi.org/10.1158/0008-5472.22393077.v1
Autor:
Elena Jachetti, Luca Generoso, Mario Santinami, Licia Rivoltini, Manuela Iero, Arianna Calcinotto, Angelo De Milito, Monica Rossetti, Giorgio Parmiani, Alessia Ricupito, Matteo Grioni, Paola Filipazzi, Rossella Canese, Agata Cova, Stefano Fais, Veronica Huber, Matteo Bellone, Martina Borghi
Publikováno v:
Cancer Research. 72:2746-2756
Stimulating the effector functions of tumor-infiltrating T lymphocytes (TIL) in primary and metastatic tumors could improve active and adoptive T-cell therapies for cancer. Abnormal glycolysis, high lactic acid production, proton accumulation, and a
Autor:
Riccardo Valdagni, Filiberto Belli, Chiara Castelli, Giorgio Parmiani, Roberto Patuzzo, Manuela Iero, Paola Filipazzi, Mario Santinami, Licia Rivoltini
Publikováno v:
Cancer Immunology, Immunotherapy. 58:1159-1167
The discovery of tumour antigens recognized by T cells and the features of immune responses directed against them has paved the way to a multitude of clinical studies aimed at boosting anti-tumour T cell immunity as a therapeutic tool for cancer pati
Autor:
Roberto Salvioni, Giorgio Parmiani, Sergio Villa, Manuela Iero, Riccardo Valdagni, Lorenzo Pilla, Licia Rivoltini, Andrea Marrari
Publikováno v:
Cancer Immunology, Immunotherapy. 56:429-445
Radical prostatectomy and radiation therapy provide excellent localized prostate cancer (PC) control. Although the majority of prostate carcinoma is nowadays diagnosed at early stages with favourable risk features, in patients up to 30-40% it recurs
Autor:
Aurélie Drouet, Jean Baptiste Latouche, Thierry Frebourg, Emilie Fauquembergue, Jérôme Leprince, Mireille Desille, Florian Cabillic, Véronique Catros, Hubert Vaudry, Olivier Toutirais, Licia Rivoltini, Cécile Thomas de La Pintière, Stéphanie Baert-Desurmont, Richard Sesboüé, David Tougeron, Matthieu Le Gallo, Manuela Iero
Publikováno v:
Journal of immunotherapy : official journal of the Society for Biological Therapy
Journal of immunotherapy : official journal of the Society for Biological Therapy, Raven Press Publishers, 2010, 33 (4), pp.402-13. ⟨10.1097/CJI.0b013e3181d366da⟩
Journal of immunotherapy : official journal of the Society for Biological Therapy, 2010, 33 (4), pp.402-13. ⟨10.1097/CJI.0b013e3181d366da⟩
Scopus-Elsevier
Journal of immunotherapy : official journal of the Society for Biological Therapy, Raven Press Publishers, 2010, 33 (4), pp.402-13. ⟨10.1097/CJI.0b013e3181d366da⟩
Journal of immunotherapy : official journal of the Society for Biological Therapy, 2010, 33 (4), pp.402-13. ⟨10.1097/CJI.0b013e3181d366da⟩
Scopus-Elsevier
International audience; Carcinoembryonic antigen (CEA) is a potential target for antigen-specific immunotherapy, as it is frequently overexpressed in human carcinomas. Moreover, an epitope derived from CEA, designated CAP1 (YLSGANLNL), has been propo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::44c52555f89d3082ba8ce4cb055582cc
https://hal.archives-ouvertes.fr/hal-00742157
https://hal.archives-ouvertes.fr/hal-00742157
Autor:
Rossella Canese, Francesco Lozupone, Mariantonia Logozzi, Antonello Villa, Angelo De Milito, Licia Rivoltini, Pamela Della Mina, Monica Rodolfo, Mario Santinami, Giulietta Venturi, Maria Marino, Elisabetta Iessi, Manuela Iero, Franca Podo, Martina Borghi, Stefano Fais
Metastatic melanoma is associated with poor prognosis and still limited therapeutic options. An innovative treatment approach for this disease is represented by targeting acidosis, a feature characterizing tumor microenvironment and playing an import
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ffca8ae5388a8fcb33e93f9e20c34099
http://hdl.handle.net/10281/18429
http://hdl.handle.net/10281/18429
Autor:
Paola Filipazzi, Roberta Valenti, Licia Rivoltini, Giorgio Parmiani, Veronica Huber, Manuela Iero
Publikováno v:
Dendritic Cells in Cancer ISBN: 9780387886107
Cancer cells constitutively release endosome-derived microvesicles, also called ‘exosomes’, carrying a broad array of molecular determinants involved in the remodeling of the peritumoral microenvironment. This recently defined alternative mechani
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::3576be33984e9a7c7d0346b78bbc0717
https://doi.org/10.1007/978-0-387-88611-4_8
https://doi.org/10.1007/978-0-387-88611-4_8
Publikováno v:
Journal of Translational Medicine, Vol 6, Iss 1, p 63 (2008)
If tumor cells are known to affect immune functions through a series of different strategies mostly relying on the release of soluble suppressive molecules, their ability of using suppressive membrane vesicles, the so called exosomes, to mould tumor
Autor:
Roberta Valenti, Paola Filipazzi, Licia Rivoltini, Veronica Huber, Manuela Iero, Stefano Fais, Giorgio Parmiani
Publikováno v:
Cell death and differentiation. 15(1)
Tumour cells release vesicular structures, defined as microvesicles or exosomes, carrying a large array of proteins from their originating cell. The expression of antigenic molecules recognized by T cells has originally suggested a role for these org
Autor:
Veronica Huber, Chiara Castelli, Paola Canese, Manuela Iero, Paola Filipazzi, Licia Rivoltini, Roberta Valenti, Luigi Mariani, Lorenzo Pilla, Giorgio Parmiani
Publikováno v:
Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 25(18)
PurposePhenotypic and functional features of myeloid suppressor cells (MSC), which are known to serve as critical regulators of antitumor T-cell responses in tumor-bearing mice, are still poorly defined in human cancers. Here, we analyzed myeloid sub